ANG-Anti-Cancer

For our anti-cancer program, we have created several conjugates of the chemotherapy drug doxorubicin and etoposide with Angiopep. We are currently testing the efficacy of these compounds as potential treatments for primary and metastatic brain cancer in the relevant pharmacological models. We don’t intent to push these products to clinical stage.